IRIS Accounts Production v23.3.0.418 11269453 Board of Directors Board of Directors 1.4.22 31.3.23 31.3.23 0 0 false true false false true false Ordinary A 1.00000 Ordinary B 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh112694532022-03-31112694532023-03-31112694532022-04-012023-03-31112694532021-03-31112694532021-04-012022-03-31112694532022-03-3111269453ns10:Originalns15:EnglandWales2022-04-012023-03-3111269453ns14:PoundSterlingns10:Original2022-04-012023-03-3111269453ns10:Originalns10:Director12022-04-012023-03-3111269453ns10:Original2022-04-012023-03-3111269453ns10:Originalns10:Director22022-04-012023-03-3111269453ns10:Original2023-03-3111269453ns10:Originalns10:PrivateLimitedCompanyLtd2022-04-012023-03-3111269453ns10:Originalns10:SmallEntities2022-04-012023-03-3111269453ns10:Originalns10:AuditExempt-NoAccountantsReport2022-04-012023-03-3111269453ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-04-012023-03-3111269453ns10:SmallCompaniesRegimeForAccountsns10:Original2022-04-012023-03-3111269453ns10:Originalns10:FullAccounts2022-04-012023-03-3111269453ns10:Original2021-04-012022-03-3111269453ns10:Originalns10:OrdinaryShareClass22022-04-012023-03-3111269453ns10:OrdinaryShareClass3ns10:Original2022-04-012023-03-3111269453ns10:Originalns10:RegisteredOffice2022-04-012023-03-3111269453ns10:Original2022-03-3111269453ns10:Originalns5:CurrentFinancialInstruments2023-03-3111269453ns10:Originalns5:CurrentFinancialInstruments2022-03-3111269453ns5:ShareCapitalns10:Original2023-03-3111269453ns5:ShareCapitalns10:Original2022-03-3111269453ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-03-3111269453ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-03-3111269453ns10:Originalns5:FurnitureFittings2022-04-012023-03-3111269453ns10:Originalns5:ComputerEquipment2022-04-012023-03-3111269453ns10:Originalns5:FurnitureFittings2022-03-3111269453ns10:Originalns5:ComputerEquipment2022-03-3111269453ns10:Original2022-03-3111269453ns10:Originalns5:FurnitureFittings2023-03-3111269453ns10:Originalns5:ComputerEquipment2023-03-3111269453ns10:Originalns5:FurnitureFittings2022-03-3111269453ns10:Originalns5:ComputerEquipment2022-03-3111269453ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-3111269453ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-03-3111269453ns10:Originalns10:OrdinaryShareClass22023-03-3111269453ns10:OrdinaryShareClass3ns10:Original2023-03-31
REGISTERED NUMBER: 11269453 (England and Wales)




































FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31ST MARCH 2023

FOR

HAMPSHIRE HEART HEALTH LIMITED

HAMPSHIRE HEART HEALTH LIMITED (REGISTERED NUMBER: 11269453)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST MARCH 2023










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


HAMPSHIRE HEART HEALTH LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31ST MARCH 2023







DIRECTORS: Dr A R Hobson
Mrs C A Hobson





REGISTERED OFFICE: Venture House
The Tanneries
East Street
Titchfield Hampshire
PO14 4AR





REGISTERED NUMBER: 11269453 (England and Wales)





ACCOUNTANTS: Compass Accountants Limited
Chartered Accountants
Venture House
The Tanneries
East Street
Titchfield
Hampshire
PO14 4AR

HAMPSHIRE HEART HEALTH LIMITED (REGISTERED NUMBER: 11269453)

BALANCE SHEET
31ST MARCH 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 1,019 1,358

CURRENT ASSETS
Debtors 5 7,935 3,933
Cash at bank 121,546 87,467
129,481 91,400
CREDITORS
Amounts falling due within one year 6 17,973 9,744
NET CURRENT ASSETS 111,508 81,656
TOTAL ASSETS LESS CURRENT
LIABILITIES

112,527

83,014

PROVISIONS FOR LIABILITIES 194 258
NET ASSETS 112,333 82,756

CAPITAL AND RESERVES
Called up share capital 7 100 100
Retained earnings 112,233 82,656
SHAREHOLDERS' FUNDS 112,333 82,756

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st March 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st March 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 16th November 2023 and were signed on its behalf by:




Dr A R Hobson - Director



Mrs C A Hobson - Director


HAMPSHIRE HEART HEALTH LIMITED (REGISTERED NUMBER: 11269453)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST MARCH 2023


1. STATUTORY INFORMATION

Hampshire Heart Health Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Revenue for the provision of services is recognised when it is probable that an economic benefit will flow to the entity and the revenue and associated costs can be reliable measured. For continuing services, revenue is recognised when the stage of completion can be reliably measured

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 25% on reducing balance
Computer equipment - 33% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Basic financial instruments
The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 1A to all of its financial instruments.

Financial instruments are recognised when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, where there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

The company's financial assets and liabilities consist of cash and cash equivalents, short term investments, trade and other debtors, trade and other creditor, and accrued expenses. The fair value of these items approximates their carrying value due to their short term value. Unless otherwise noted, the company is not exposed to significant interest, foreign exchange or credit risks arising from these instruments.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2022 - NIL).

HAMPSHIRE HEART HEALTH LIMITED (REGISTERED NUMBER: 11269453)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31ST MARCH 2023


4. TANGIBLE FIXED ASSETS
Fixtures
and Computer
fittings equipment Totals
£    £    £   
COST
At 1st April 2022
and 31st March 2023 2,850 1,000 3,850
DEPRECIATION
At 1st April 2022 1,492 1,000 2,492
Charge for year 339 - 339
At 31st March 2023 1,831 1,000 2,831
NET BOOK VALUE
At 31st March 2023 1,019 - 1,019
At 31st March 2022 1,358 - 1,358

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 7,662 3,933
Other debtors 273 -
7,935 3,933

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Taxation and social security 14,137 7,812
Other creditors 3,836 1,932
17,973 9,744

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: £    £   
50 Ordinary A 1.00 50 50
50 Ordinary B 1.00 50 50
100 100